Close this search box.

How Smart Public Policies Can Curb Hepatitis C

The coronavirus pandemic proved that the public health response to a large-scale crisis can literally mean the difference between life and death. That lesson can now be applied to a different public health issue – hepatitis C.

Policymakers Increase Efforts to Eliminate Hepatitis C

Direct-acting antivirals, which provide about a 90 percent cure rate, can prevent cirrhosis and liver cancer, reducing the number of liver transplants needed, and minimizing disease transmission.  The initial list price of the drugs gave many insurers and health systems sticker shock, though market forces continue to drive down the price.